(1) What amount has been spent on chronic medicine in respect of (a) diabetic and (b) high blood pressure illnesses (i) in the 2011-12 financial year and (ii) from 1 April 2012 up to the latest specified date for which information is available; (2) whether there have been any (a) shortages and/or (b) backlogs in the delivery of medicines from 1 January 2012 up to the latest specified date for which information is available to (i) Health Care Centres and (ii) hospitals; if not, what is the position in this regard; if so, (aa) what are the reasons for the shortages and/or backlogs and (bb) what are the further relevant details; (3) whether any measures have been put in place to ensure that facilities do not have shortages in this regard; if not, why not; if so, what are the relevant details?